News
Vincerx common stock suspended by Nasdaq inadvertently; will resume trading at the open of business on April 21, 2025 Trading to be permanently suspended by Nasdaq at the open of business on April 23 ...
Lifecore Biomedical, Inc.: Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Lifecore Biomedical, Inc. (NASDAQ: LFCR) ("Lifecore") a fully integrated contract development and manufacturing organization ("CDMO"), today announced ...
The Boston Business Journal recognizes the top chief financial officers who deliver the most outstanding performance for their Massachusetts companies.
Short interest in Legend Biotech Corp (NASDAQ ... this short interest to close out their positions without sending the stock sharply higher.
11d
Stocktwits on MSNAerovate Therapeutics Stock Bucks Broader Market Sell-Off Over Dividend Announcement: Stock Rises But Retail’s UnmovedShares of biotechnology company Aerovate Therapeutics, Inc. (AVTE) rose by over 1% on Monday morning after the company ...
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves ...
it's possible to buy shares of quality stocks with $50 -- or less. Viking Therapeutics, a mid-cap biotech, is looking to make waves in the fast-growing market for weight management medicines.
Stocks fought their way higher Wednesday as Wall Street braced for the expected rollout of President Donald Trump’s tariffs.
The delisting decision comes as a significant setback for Aptose, which was unable to meet the Nasdaq’s equity rule by the March 31 deadline, marking the limit of the Panel’s discretion to allow ...
Among vaccine stocks, clinical-stage biotech Vaxcyte PCVX suffered the largest decline, with its shares plummeting nearly 46%. The fall in PCVX shares was further amplified by mixed results from a ...
BOCA RATON, FL / ACCESS Newswire / March 31, 2025 / Newsmax Inc. ("Newsmax" or the "Company") announced that its Class B Common Stock will begin trading this morning on the New York Stock Exchange ...
bluebird bio Inc. (NASDAQ:BLUE), a biotechnology company with a market ... The company finds itself at a critical juncture, with its stock down over 84% in the past year. The company’s financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results